Lumen Biomedical
Maple Grove
About Lumen Biomedical
Lumen Biomedical, Inc. develops and commercializes interventional devices for embolic protection and thrombus removal throughout the body. It offers FiberNet embolic protection systems for the treatment of patients receiving endovascular intervention for carotid artery diseases; and Xtract, a thrombus aspiration catheter device that supports the care of segment elevation myocardial infarction. The company’s products are used in carotid artery procedures. It serves customers through distributors in the United States and Europe. The company was founded in 2003 and is based in Maple Grove, Minnesota.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Total funding: $675.0K
- Last round: Series Unknown (Oct 2009)
- Website: lumenbio.com
- Phone: 763-577-9600
Industries & Categories
Biotechnology, Health Care, Medical Device
Canonical: https://fsome.com/organization/lumen-biomedical-2324491 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.